Navigation Links
Novartis Drug Afinitor® Recommended by FDA Oncology Advisory Committee for Approval to Treat Advanced NET of Pancreatic Origin
Date:4/12/2011

t of RADIANT-3 is progression-free survival (PFS). Secondary endpoints include safety, objective response rate (confirmed according to RECIST), duration of response and overall survival(1).

Results from the trial showed that everolimus more than doubled median PFS from 4.6 to 11.0 months when compared with placebo and reduced the risk of cancer progression by 65% (hazard ratio=0.35 [95% CI, 0.27 to 0.45]; p<0.001) in patients with advanced pancreatic NET(1).

In the study, everolimus maintained a safety profile consistent with the prescribing information and previous studies of the drug. The most frequent all grade, drug-related adverse events (greater than or equal to 20%) were stomatitis/oral mucositis/ulcers (64% everolimus vs. 17% placebo; includes stomatitis, aphthous stomatitis, mouth ulceration and tongue ulceration), rash (49% vs. 10%), diarrhea (34% vs. 10%), fatigue (31% vs. 14%), infections (23% vs. 6%), nausea (20% vs. 18%), peripheral edema (20% vs. 3%) and decreased appetite (20% vs. 7%); most were grade one or two. Grade three and four adverse events (greater than or equal to 5%) include stomatitis/oral mucositis/ulcers (7% vs. 0%; includes stomatitis, aphthous stomatitis, mouth ulceration and tongue ulceration), anemia (6% vs. 0%) and hyperglycemia (5% vs. 2%). Median exposure to everolimus was 2.3-fold longer than exposure to placebo (38 vs. 16 weeks)(1).

About Afinitor (everolimus)Afinitor® (everolimus) tablets is approved in the US for the treatment of patients with advanced renal cell carcinoma (RCC) after failure of treatment with sunitinib or sorafenib and in the European Union (EU) for the treatment of patients with advanced RCC whose disease has progressed on or after treatment with vascular endothelial growth factor (VEGF)-targeted therapy.

Afinitor is also approved in the US to treat patients with subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis who require therapeut
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. US Supreme Court Denies Certiorari and Thereby Leaves in Place Second Circuit Ruling That Novartis Pharmaceuticals Corporation Must Pay its Sales Representatives Overtime Compensation
2. Novartis Gains FDA Approval for Amturnide™, a Triple-Combination Pill to Treat High Blood Pressure in Patients Uncontrolled on Two Medications
3. Study Shows Novartis Drug Afinitor® Plus Hormonal Therapy Delays Disease Progression in Advanced Metastatic Breast Cancer Patients
4. Novartis Phase II LBH589 data show substantial disease control and tumor reduction in extensively pretreated Hodgkin lymphoma patients
5. Phase III Data Published in Lancet Show Novartis Drug Zometa® Improves Overall Survival in Newly Diagnosed Multiple Myeloma Patients
6. Final Approval of Novartis Gender Discrimination Settlement Slated for November 19
7. Study in NEJM Shows Novartis Drug Afinitor® Reduces Size of SEGAs, Benign Brain Tumors Associated with Tuberous Sclerosis
8. VIDEO from thenewsmarket.com and Novartis: Novartis drug Afinitor® Approved by FDA as First Medication for Children and Adults With a Benign Brain Tumor Associated With Tuberous Sclerosis
9. Novartis to Expand Global Research Headquarters in Cambridge, MA
10. VIDEO From thenewsmarket.com and Novartis: Phase III Data Show That Novartis Meningococcal Vaccine Menveo® Demonstrated Robust Immunogenicity in Infants
11. Analysis Shows Novartis Drug TOBI® Associated With Reduced Mortality in Cystic Fibrosis Patients With Common Lung Infection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... Md. , Jan. 23, 2015  Northwest Biotherapeutics, Inc. (NASDAQ: ... DCVax® personalized immune therapies for operable and inoperable solid tumor ... present at the 7 th Annual Phacilitate Immunotherapy Forum ... Bio,s presentation at Phacilitate will take place on January 26 ...
(Date:1/23/2015)... Jan. 23, 2015 More than a third of reproductive-aged ... those with private insurance, filled a prescription for an opioid ... in this week,s Morbidity and Mortality Weekly Report (MMWR). ... to treat moderate to severe pain.  They are also found ...
(Date:1/23/2015)... /PRNewswire/-- Harwood Feffer LLP ( www.hfesq.com ) is investigating potential ... ("Advaxis" or the "Company") (NASDAQ: ADXS ), ... to shareholders. On January 21, 2015, an ... Advaxis had misrepresented the clinical data for its ADXS-HPV ...
Breaking Medicine Technology:NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 2NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 3Opioid painkillers widely prescribed among reproductive age women 2Opioid painkillers widely prescribed among reproductive age women 3Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2
... 2010 Reportlinker.com announces that a new market research ... Global Medical Specialty Bags Industry ... worldwide markets for Medical Specialty Bags in US$ Million ... Blood Bags, Breathing Bags, Cadaver Bags, Enema Bags, Enteral ...
... FRANKLIN LAKES, N.J., Nov. 15, 2010 Medco Health ... that its 2011 Medco Medicare Prescription Plan® earned the ... quality and performance rating – 5 Stars – for ... relative quality of the private plans that are offered ...
Cached Medicine Technology:Reportlinker Adds Global Medical Specialty Bags Industry 2Reportlinker Adds Global Medical Specialty Bags Industry 3Reportlinker Adds Global Medical Specialty Bags Industry 4Reportlinker Adds Global Medical Specialty Bags Industry 5Reportlinker Adds Global Medical Specialty Bags Industry 6Reportlinker Adds Global Medical Specialty Bags Industry 7Reportlinker Adds Global Medical Specialty Bags Industry 8Reportlinker Adds Global Medical Specialty Bags Industry 9Reportlinker Adds Global Medical Specialty Bags Industry 10Reportlinker Adds Global Medical Specialty Bags Industry 11Reportlinker Adds Global Medical Specialty Bags Industry 12Reportlinker Adds Global Medical Specialty Bags Industry 13Reportlinker Adds Global Medical Specialty Bags Industry 14Reportlinker Adds Global Medical Specialty Bags Industry 15Reportlinker Adds Global Medical Specialty Bags Industry 16Reportlinker Adds Global Medical Specialty Bags Industry 17Reportlinker Adds Global Medical Specialty Bags Industry 18Reportlinker Adds Global Medical Specialty Bags Industry 19Reportlinker Adds Global Medical Specialty Bags Industry 20Reportlinker Adds Global Medical Specialty Bags Industry 21Reportlinker Adds Global Medical Specialty Bags Industry 22Reportlinker Adds Global Medical Specialty Bags Industry 23Medco's 2011 National Medicare Prescription Drug Plan (PDP) Earns CMS 5-Star Quality and Performance Rating 2Medco's 2011 National Medicare Prescription Drug Plan (PDP) Earns CMS 5-Star Quality and Performance Rating 3Medco's 2011 National Medicare Prescription Drug Plan (PDP) Earns CMS 5-Star Quality and Performance Rating 4
(Date:1/22/2015)... The U.S. Pharmacopeial Convention is pleased to ... Pharmacy Services at North Carolina State’s College of Veterinary ... Beal Award for Distinguished Volunteer Service—the organization’s highest award. ... contributions of volunteer experts to direct its work to ...
(Date:1/22/2015)... Gabe’s Chemo Duck Program is pleased to announce the ... created for kids with cancer. The Chemo Duck App, available on ... with enjoyable games to help children of all ages living with ... to keep kids entertained, educated and at ease while waiting for ...
(Date:1/22/2015)... Blue Cross and Blue Shield of Minnesota (Blue Cross) ... to “Live Fearless.” , The “Faces of Fearless” ... about how they or someone they know has faced a ... the moment. By telling these types of stories through livefearlessmn.com, ...
(Date:1/22/2015)... January 22, 2015 Thousand of GranuFlo ... Care recalled its GranuFlo and NaturaLyte dialysis concentrates continue ... in U.S. District Court, District of Massachusetts, Bernstein Liebhard ... the Court has remanded a case filed by the ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 A ... Sports Medicine flagship journal Medicine & Science in ... before exercise may help reduce gastrointestinal (GI) problems ... , Participants in the double-blind, placebo-controlled study ...
Breaking Medicine News(10 mins):Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 2Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 3Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 4Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 3Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3
... of India's most polluted rivers due to callous industries as ... , says a new study. ,A once clean ... urban towns, carrying a heavy load of pesticides released both ... fields, says the report released by Janhit Foundation., ,The ...
... University of Belgium, on Tuesday claimed that they have ... ,According to the reports, the Belgium scientists have used ... mouse-ear cress) to produce antibodies against the Hepatitis A ... drugs that are effective in fighting cancer and infections. ...
... fallen by 60% worldwide since 1999 is a major ... to halve measles deaths between 1999 and 2005 // ... in measles deaths in the African region. The progress ... the American Red Cross, the United States Centers for ...
... circumcision could reduce a man's risk of HIV infection ... Ru Xiaomei, deputy director general of China's National Population ... U.K. reports. ,Data from two studies conducted ... indicate that routine male circumcision could reduce a man's ...
... outbreak of the deadly Rift valley Fever (RVF) in neighboring ... // ,This is however despite reports that ... disease. ,Consumption of raw milk being peddled ... to be dangerous, not only due to hygienic concerns but ...
... now been discovered in India.,Sleeping sickness or Human trypanosomiases ... it is called Chagas disease. ,A farmer ... Chandrapur) 140 km from Nagpur in the central State ... confirmed case of human trypanosomiasis recorded in this country. ...
Cached Medicine News:Health News:Act Now To Cleanse Highly Polluted River Hindon, Says Study 2Health News:Global Goal to Reduce Measles Deaths in Children Surpassed 2Health News:Global Goal to Reduce Measles Deaths in Children Surpassed 3Health News:Global Goal to Reduce Measles Deaths in Children Surpassed 4Health News:Experts Warn Against Raw Milk Following Rift Valley Fever Outbreak in Kenya 2Health News:Experts Warn Against Raw Milk Following Rift Valley Fever Outbreak in Kenya 3Health News:Sleeping Sickness Comes to India 2
Standard reading test. 'It was the month of May'...
... Low Contrast Flip charts contain 5 pages of ... each page. Optotype size is 9.5M. Contrast levels ... flip charts can be used at several different ... same test. Each offers a different set ...
Directional `E' and `C' test....
9" X 14" translucent plastic may be used with illuminated test cabinet or as a wall chart 20/200 to 20/15....
Medicine Products: